| __timestamp | Catalyst Pharmaceuticals, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 4241601.57 |
| Thursday, January 1, 2015 | 8597010 | 5392385.38 |
| Friday, January 1, 2016 | 7910260 | 7370036.73 |
| Sunday, January 1, 2017 | 7304399 | 14970357 |
| Monday, January 1, 2018 | 15875961 | 31413266 |
| Tuesday, January 1, 2019 | 36881187 | 72279461 |
| Wednesday, January 1, 2020 | 44233754 | 183907682 |
| Friday, January 1, 2021 | 49628000 | 307644000 |
| Saturday, January 1, 2022 | 58183000 | 472132000 |
| Sunday, January 1, 2023 | 133710000 | 709539000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability and operational efficiency. This analysis compares the SG&A cost management of two prominent companies: argenx SE and Catalyst Pharmaceuticals, Inc., from 2014 to 2023.
Over the past decade, argenx SE has seen a significant increase in SG&A expenses, peaking at approximately 709% of their 2014 levels by 2023. This growth reflects their aggressive expansion and investment in research and development. In contrast, Catalyst Pharmaceuticals, Inc. has managed a more conservative increase, with their SG&A expenses rising by about 299% over the same period.
While argenx SE's strategy indicates a robust growth trajectory, Catalyst Pharmaceuticals' approach suggests a focus on cost efficiency. Investors and stakeholders should consider these trends when evaluating the financial health and strategic direction of these companies.
Operational Costs Compared: SG&A Analysis of AbbVie Inc. and Catalyst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Intra-Cellular Therapies, Inc.
Who Optimizes SG&A Costs Better? argenx SE or Pharming Group N.V.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and HUTCHMED (China) Limited
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.